Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01579552 · ClinicalTrials.gov registry record · Phase 3

Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer

A Phase 3 study of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
Phase 3
Development phase
360
Enrollment target
2
Study locations

NCT01579552: Active Phase 3 study of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01579552 is a Phase 3 study of Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 360 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01579552, a Phase 3 study of Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
360 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to empower women to improve their health in two very important areas: breast and heart health. This twelve-month study will compare two methods of informing participants about potential health risks and ways to stay healthy. The EMPOWER Study has been designed for adult women who were treated for a childhood cancer with chest radiation.

Conditions Studied

Interventions

  • BEHAVIORAL survey, questionaire

Study Locations (2)

New York

  • Memorial Sloan Kettering Cancer Center (All protocol activities) - New York

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2010-07
Est. Completion 2026-07
Phase Phase 3

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT01579552

The ClinicalTrials.gov registry entry for NCT01579552 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which survey, questionaire is the first listed.

NCT01579552 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Tennessee.

Frequently Asked Questions

What is clinical trial NCT01579552 about?

NCT01579552 is a clinical study titled "Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer". The purpose of this study is to empower women to improve their health in two very important areas: breast and heart health. This twelve-month study will compare two methods of informing participants about potential health risks and ways to stay healthy. The EMPOWER Study has been designed for adult...

What is the current status of trial NCT01579552?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2010-07. Estimated completion is 2026-07.

What conditions does trial NCT01579552 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT01579552?

The interventions under investigation include: survey, questionaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT01579552?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01579552 being conducted?

This trial has 2 study locations across New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.